Invention Grant
- Patent Title: Genomic classification of malignant melanoma based on patterns of gene copy number alterations
- Patent Title (中): 基于基因拷贝数变化模式的恶性黑素瘤基因组分类
-
Application No.: US12607080Application Date: 2009-10-28
-
Publication No.: US08498821B2Publication Date: 2013-07-30
- Inventor: Dimitri Semizarov , Xin Lu , Ke Zhang , Rick R. Lesniewski
- Applicant: Dimitri Semizarov , Xin Lu , Ke Zhang , Rick R. Lesniewski
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G01N33/50 ; G01N31/00 ; G06G7/48 ; G06F19/00
Abstract:
The invention is directed to methods and kits that allow for classification of malignant melanoma cells according to genomic profiles, and methods of diagnosing, predicting clinical outcomes, and stratifying patient populations for clinical testing and treatment using the same.
Public/Granted literature
- US20100145897A1 GENOMIC CLASSIFICATION OF MALIGNANT MELANOMA BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONS Public/Granted day:2010-06-10
Information query
